The arylamine N-acetyltransferases as therapeutic targets in metabolic diseases associated with mitochondrial dysfunction.
Article in Pharmacological Reviews (December 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Pharmacological Reviews (December 2023)
Article in Frontiers in Pharmacology (October 2022)
Article in International Journal of Molecular Sciences (March 2022)